8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T62264 | SARS-CoV-2 nsp13-IN-2 | ||
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 42 μM). | |||
T62413 | SARS-CoV-2 nsp13-IN-1 | ||
SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent inhibitor of nsp13 (non-structural protein 13). SARS-CoV-2 nsp13-IN-1 inhibits only nsp13 ssDNA+ATPase (IC50: 6 μM), but not ssDNA-ATPase. CoV-2 nsp13-IN-1 was able to be u... | |||
T63615 | SARS-CoV-2 nsp13-IN-5 | ||
SARS-CoV-2 nsp13-IN-5 is a potent inhibitor of SARS-CoV-2 nsp13, capable of acting on ssDNA+ATPase (IC50: 50 μM) and ssDNA-ATPase (IC50: 55 μM). SARS-CoV-2 nsp13-IN-5 can be used in anti-COVID-19 studies. | |||
T62031 | SARS-CoV-2 nsp13-IN-4 | ||
SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective small-molecule inhibitor of nsp13 helicase. SARS-CoV-2 nsp13-IN-4 inhibits the ssDNA+ ATPase activity of nsp13 with an IC 50 of 57 μM. SARS-CoV-2 nsp13-IN-4 can pr... | |||
T62375 | SARS-CoV-2 nsp13-IN-3 | ||
SARS-CoV-2 nsp13-IN-3 (Compound C3) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 32 μM). | |||
T62248 | SARS-CoV-2 nsp13-IN-6 | ||
SARS-CoV-2 nsp13-IN-6 (compound C5) is a potent inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on ssDNA+ATPase (IC50: 27 μM) and ssDNA-ATPase (IC50: 33 μM). nsp13-IN-6 can be used in anti-COVID-19 st... | |||
T63950 | SARS-CoV-2-IN-19 | ||
SARS-CoV-2-IN-19 is a potent inhibitor of SARS-CoV-2 (EC50: 8.8 μM). SARS-CoV-2-IN-19 is effective against SARS-CoV-2 decapping enzyme (nsp13), a highly conserved enzyme that exhibits potential against emerging HCoV outb... | |||
T61523 | FWM-5 | ||
FWM-5 is a powerful inhibitor of NSP13 helicase, a key enzyme in the life cycle of the SARS-CoV-2 virus. With its potential in researching infectious diseases, FWM-5 emerges as a promising compound [1]. |